Clinical Trial Update: A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of the investigational agent BLYG8824A in locally advanced or metastatic colorectal cancer has completed. The trial was sponsored by Genentech, In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BLYG8824A

Snippet

Sponsor: Genentech, Inc. | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED